Aldeyra Therapeutics eye treatment meets late-stage study main goal
15/06/2023 12:08
June 15 (Reuters) - Aldeyra Therapeutics ALDX.O said on Thursday its experimental drug to treat an inflammatory eye disease met the main goal of reducing itching in a late-stage study. (Reporting by Mariam Sunny in Bengaluru Editing by Vinay Dwivedi) ((Mariam.ESunny@thomsonreuters.com;))
Recent news on Aldeyra Therapeutics
See all newsBrief: Aldeyra Therapeutics Pays Off $15 Million Outstanding Borrowings, Terminates Hercules Credit Facility - SEC Filing
U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora
U.S. STOCKS ON THE MOVE-Qualcomm, Canadian Solar, Draftkings
Aldeyra tumbles to record low after FDA declines to approve experimental dry eye drug
Aldeyra plunges after FDA declines to approve experimental dry eye drug